These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12417453)

  • 1. Working memory and apolipoprotein E: what's the connection?
    Rosen VM; Bergeson JL; Putnam K; Harwell A; Sunderland T
    Neuropsychologia; 2002; 40(13):2226-33. PubMed ID: 12417453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease.
    Rosen VM; Sunderland T; Levy J; Harwell A; McGee L; Hammond C; Bhupali D; Putnam K; Bergeson J; Lefkowitz C
    Neuropsychologia; 2005; 43(4):647-58. PubMed ID: 15716154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
    Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults.
    Flory JD; Manuck SB; Ferrell RE; Ryan CM; Muldoon MF
    Am J Med Genet; 2000 Dec; 96(6):707-11. PubMed ID: 11121165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.
    Growdon JH; Locascio JJ; Corkin S; Gomez-Isla T; Hyman BT
    Neurology; 1996 Aug; 47(2):444-8. PubMed ID: 8757018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
    Caselli RJ; Reiman EM; Hentz JG; Osborne D; Alexander GE; Boeve BF
    Sleep; 2002 Jun; 25(4):447-53. PubMed ID: 12071547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores.
    Bondi MW; Houston WS; Salmon DP; Corey-Bloom J; Katzman R; Thal LJ; Delis DC
    J Int Neuropsychol Soc; 2003 Jul; 9(5):783-95. PubMed ID: 12901784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
    Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
    Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.
    Hirono N; Hashimoto M; Yasuda M; Kazui H; Mori E
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):354-8. PubMed ID: 12928512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual short-term memory binding deficits in familial Alzheimer's disease.
    Parra MA; Abrahams S; Logie RH; Méndez LG; Lopera F; Della Sala S
    Brain; 2010 Sep; 133(9):2702-13. PubMed ID: 20624814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.